Evercore ISI Trims Zimmer Biomet (NYSE:ZBH) Target Price to $113.00

Zimmer Biomet (NYSE:ZBH – Free Report) had its price target reduced by Evercore ISI from $115.00 to $113.00 in a research note released on Thursday, Benzinga reports. They currently have an in-line rating on the medical equipment provider’s stock. A number of other research analysts have also recently issued reports on the stock. Citigroup decreased […]

Leave a Reply

Your email address will not be published.

Previous post South Korea July 2024: Kia back to #1, EV3 lands
Next post FONAR (NASDAQ:FONR) Upgraded at StockNews.com